Moreover, Foxp3+ Tregs maintained amphiregulin production at diabetes onset (Fig. 1f), suggesting that islet-resident Tregs retain the capacity to produce amphiregulin throughout the course of disease. This evidence concerns the gene FOXP3 and diabetes mellitus.